1. Home
  2. HRZN vs PRME Comparison

HRZN vs PRME Comparison

Compare HRZN & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRZN
  • PRME
  • Stock Information
  • Founded
  • HRZN 2008
  • PRME 2019
  • Country
  • HRZN United States
  • PRME United States
  • Employees
  • HRZN N/A
  • PRME N/A
  • Industry
  • HRZN Finance/Investors Services
  • PRME Medicinal Chemicals and Botanical Products
  • Sector
  • HRZN Finance
  • PRME Health Care
  • Exchange
  • HRZN Nasdaq
  • PRME Nasdaq
  • Market Cap
  • HRZN 396.1M
  • PRME 424.9M
  • IPO Year
  • HRZN 2010
  • PRME 2022
  • Fundamental
  • Price
  • HRZN $8.85
  • PRME $2.90
  • Analyst Decision
  • HRZN Sell
  • PRME Strong Buy
  • Analyst Count
  • HRZN 6
  • PRME 9
  • Target Price
  • HRZN $9.35
  • PRME $13.13
  • AVG Volume (30 Days)
  • HRZN 530.6K
  • PRME 1.3M
  • Earning Date
  • HRZN 10-29-2024
  • PRME 11-12-2024
  • Dividend Yield
  • HRZN 14.91%
  • PRME N/A
  • EPS Growth
  • HRZN N/A
  • PRME N/A
  • EPS
  • HRZN N/A
  • PRME N/A
  • Revenue
  • HRZN $104,553,000.00
  • PRME $800,000.00
  • Revenue This Year
  • HRZN N/A
  • PRME N/A
  • Revenue Next Year
  • HRZN $7.48
  • PRME $426.55
  • P/E Ratio
  • HRZN N/A
  • PRME N/A
  • Revenue Growth
  • HRZN N/A
  • PRME N/A
  • 52 Week Low
  • HRZN $8.46
  • PRME $2.56
  • 52 Week High
  • HRZN $13.73
  • PRME $9.80
  • Technical
  • Relative Strength Index (RSI)
  • HRZN 34.49
  • PRME 41.76
  • Support Level
  • HRZN $8.65
  • PRME $2.56
  • Resistance Level
  • HRZN $9.02
  • PRME $3.04
  • Average True Range (ATR)
  • HRZN 0.20
  • PRME 0.25
  • MACD
  • HRZN -0.03
  • PRME -0.01
  • Stochastic Oscillator
  • HRZN 39.39
  • PRME 36.17

About HRZN Horizon Technology Finance Corporation

Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services and sustainability industries.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: